After PSA screening, MRI-targeted vs. systematic biopsy detected fewer clinically insignificant prostate cancers
- PMID: 37011398
- DOI: 10.7326/J23-0017
After PSA screening, MRI-targeted vs. systematic biopsy detected fewer clinically insignificant prostate cancers
Abstract
Hugosson J, Månsson M, Wallström J, et al. Prostate cancer screening with PSA and MRI followed by targeted biopsy only. N Engl J Med. 2022;387:2126-37. 36477032.
Comment on
-
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only.N Engl J Med. 2022 Dec 8;387(23):2126-2137. doi: 10.1056/NEJMoa2209454. N Engl J Med. 2022. PMID: 36477032 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous